So, again, from a clinical perspective, late presentations or later presentations mean more complexity for that person as well.

Yeah, I think like you say, there's burdens that come in at the beginning to get them onto the pathway.

And then from my side, I see more kind of what's then when they're already referred and they're into either a symptomatic or a screening pathway, that actually there's also then a capacity issue even once they're in the system.

If you think about the demand for breast imaging, again, we've got a genuine radiologist and radiographer shortage there.

And so when that capacity is stretched, the waiting times grow further as well.

And you've already sort of touched on the point of how long some people can be waiting.

I think thankfully in breast, it's not as long as it is in some of the gynae pathways.

So with AI and new imaging technologies emerging and evolving rapidly, what innovations are you most hopeful about in terms of improving accuracy, reducing variation, or supporting earlier diagnosis for women? Anna, I might start with you if that's okay.